<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Fidelity Freedom 2020 Fund Class K — News on 6ix</title>
    <link>https://6ix.com/company/fidelity-freedom-2020-fund-class-k</link>
    <description>Latest news and press releases for Fidelity Freedom 2020 Fund Class K on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/fidelity-freedom-2020-fund-class-k" rel="self" type="application/rss+xml" />
    <item>
      <title>The Manitowoc Company Schedules First-Quarter 2026 Earnings Announcement and Conference Call</title>
      <link>https://6ix.com/company/fidelity-freedom-2020-fund-class-k/news/the-manitowoc-company-schedules-first-quarter-2026-earnings-announcement-and-conference-call-9</link>
      <guid isPermaLink="true">https://6ix.com/company/fidelity-freedom-2020-fund-class-k/news/the-manitowoc-company-schedules-first-quarter-2026-earnings-announcement-and-conference-call-9</guid>
      <pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
      <description>MILWAUKEE, Wis.--(BUSINESS WIRE)-- The Manitowoc Company, Inc. (NYSE: MTW) announced today that it will release its first-quarter 2026 results on Tuesday,</description>
    </item>
    <item>
      <title>Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States</title>
      <link>https://6ix.com/company/fidelity-freedom-2020-fund-class-k/news/wave-life-sciences-announces-hearing-on-proposed-redomiciliation-to-the-united-states-2</link>
      <guid isPermaLink="true">https://6ix.com/company/fidelity-freedom-2020-fund-class-k/news/wave-life-sciences-announces-hearing-on-proposed-redomiciliation-to-the-united-states-2</guid>
      <pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
      <description>CAMBRIDGE, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company</description>
    </item>
  </channel>
</rss>